ACRS: חוב לטווח קצר של החברה Aclaris Therapeutics

The daily price chart for Aclaris Therapeutics (ACRS) reflects the dynamics of a company with a metric of 0.00. The business relies on the development of proprietary anti-inflammatory drugs, while alliances with industry behemoths strengthen its market position. Aclaris Therapeutics (ACRS) specializes in dermatology and immunology, utilizing exclusive molecules to establish high pricing power for the treatment of complex pathologies.

This indicator measures the aggregate of financial obligations due within twelve months, which is critical for assessing liquidity. An increase in this figure signals higher default risks in the event of cash flow gaps. By analyzing an organization's short-term debt via GURU.Markets, an investor can track borrowing trends. For Aclaris Therapeutics (ACRS), this parameter reflects the dependence of biotechnological developments on external financing. Monitoring this metric determines capital stability while awaiting trial results.